Manufacturing radioactive compounds in-house offers new opportunities for the treatment of patients. It is now possible to use short-living radionuclides. These have to reach the patient without any delay, often within minutes. Therefore, it is impossible to procure them from other suppliers. Having our own cyclotron facility also provides us with new research opportunities, e.g. for the diagnosis of cancer. Our own cyclotron makes us independent from external suppliers and allows us to obtain the required experimental compounds at any time. Hospitals in the vicinity of Radboudumc can also benefit from the new cyclotron facility.